GU Cancers 2024 | The emerging role of gene therapies for bladder cancer

Siamak Daneshmand, MD, University of Southern California, Los Angeles, CA, comments on the future of gene therapies for bladder cancer. Multiple gene therapies with varying mechanisms of action are under development and the use of oncolytic viruses will hopefully enable future agents to generate an immune response in addition to directly targeting the tumor. This interview took place at the ASCO GU Cancers Symposium 2024 in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.